Kremer J, Bingham C, Cappelli L, et al. Post-appoval comparative safety study of tofacitinib and biological DMARDS: five-year results from a US-based rheumatoid arthritis registry. EULAR 2019; Madrid: Abstract OP0028.
UMCG start onderzoek naar toepassing van bacteriofagen
dec 2023 | Antibioticaresistentie, Artrose, Bacteriële infecties